ALTO-207 in Adults With Treatment-resistant Depression (TRD)

Clinical trial NCT07553637 · RECRUITING

Trial details

NCT number: NCT07553637
Sponsor: Alto Neuroscience
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment-resistant Depression (TRD)

Start date: 2026-05-01
Primary completion: 2027-11-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.